{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:23:53Z","timestamp":1783664633627,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"National Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["GZY-KJS-ZJ-2026-013"],"award-info":[{"award-number":["GZY-KJS-ZJ-2026-013"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LHDMZ26H030002"],"award-info":[{"award-number":["LHDMZ26H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.exger.2026.113036","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:12:37Z","timestamp":1768407157000},"page":"113036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Telomere length and metabolic dysfunction-associated steatotic liver disease risk and progression: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"214","author":[{"given":"Chunfeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.exger.2026.113036_bb0005","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.exger.2026.113036_bb0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s12072-024-10701-6","article-title":"Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation","volume":"18","author":"Alarabi","year":"2024","journal-title":"Hepatol. Int."},{"issue":"3","key":"10.1016\/j.exger.2026.113036_bb0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2012.10.031","article-title":"Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease","volume":"58","author":"Aravinthan","year":"2013","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.exger.2026.113036_bb0020","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/jcsm.13243","article-title":"Sarcopenia and health-related quality of life: a systematic review and meta-analysis","volume":"14","author":"Beaudart","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"6808","key":"10.1016\/j.exger.2026.113036_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/35040500","article-title":"Telomere states and cell fates","volume":"408","author":"Blackburn","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.exger.2026.113036_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11684-025-1133-7","article-title":"Aging and metabolic dysfunction-associated steatotic liver disease: a bidirectional relationship","volume":"19","author":"Chen","year":"2025","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.exger.2026.113036_bb0035","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4093\/dmj.2024.0641","article-title":"Metabolic dysfunction-associated Steatotic liver disease and risk of hepatocellular carcinoma in type 2 diabetes mellitus","volume":"49","author":"Cho","year":"2025","journal-title":"Diabetes Metab. J."},{"issue":"4","key":"10.1016\/j.exger.2026.113036_bb0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ggi.13257","article-title":"Frailty index from routine laboratory measurements correlates with leukocyte telomere length","volume":"18","author":"Dent","year":"2018","journal-title":"Geriatr Gerontol Int"},{"issue":"6","key":"10.1016\/j.exger.2026.113036_bb0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.21037\/atm.2020.03.10","article-title":"Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients","volume":"8","author":"Dong","year":"2020","journal-title":"Ann Transl Med."},{"issue":"4","key":"10.1016\/j.exger.2026.113036_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000539371","article-title":"EASL-EASD-EASO clinical practice guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","volume":"17","year":"2024","journal-title":"Obes. Facts"},{"issue":"3","key":"10.1016\/j.exger.2026.113036_bb0055","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.exger.2026.113036_bb0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease Spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.exger.2026.113036_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101833","article-title":"Emerging role of aging in the progression of NAFLD to HCC","volume":"84","author":"He","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.exger.2026.113036_bb0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.exger.2009.02.006","article-title":"Telomere length-heterogeneity among myeloid cells is a predictor for chronological ageing","volume":"44","author":"Hoffmann","year":"2009","journal-title":"Exp. Gerontol."},{"issue":"12","key":"10.1016\/j.exger.2026.113036_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13523","article-title":"Cisd2 slows down liver aging and attenuates age-related metabolic dysfunction in male mice","volume":"20","author":"Huang","year":"2021","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.exger.2026.113036_bb0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.18632\/aging.101743","article-title":"Loss of GPR109A\/HCAR2 induces aging-associated hepatic steatosis","volume":"11","author":"Jadeja","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.exger.2026.113036_bb0085","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.exger.2026.113036_bb0090","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/liv.13886","article-title":"Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis","volume":"38","author":"Kim","year":"2018","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.exger.2026.113036_bb0095","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3350\/cmh.2024.0691","article-title":"Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause\/cause-specific mortality","volume":"30","author":"Kim","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"issue":"6","key":"10.1016\/j.exger.2026.113036_bb0100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study","volume":"57","author":"Koehler","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.exger.2026.113036_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/00365513.2022.2059698","article-title":"Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study","volume":"82","author":"Korkiakoski","year":"2022","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1\u20132","key":"10.1016\/j.exger.2026.113036_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2009.09.012","article-title":"Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance","volume":"352","author":"Lin","year":"2010","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.exger.2026.113036_bb0115","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.exger.2026.113036_bb0120","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/ije\/dyv169","article-title":"Is southern blotting necessary to measure telomere length reproducibly? Authors\u2019 response to: commentary: the reliability of telomere length measurements","volume":"44","author":"Martin-Ruiz","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.exger.2026.113036_bb0125","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.exger.2026.113036_bb0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jdi.12555","article-title":"Deoxyribonucleic acid telomere length shortening can predict the incidence of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"8","author":"Ping","year":"2017","journal-title":"J Diabetes Investig."},{"key":"10.1016\/j.exger.2026.113036_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221145549","article-title":"MAFLD: a multisystem disease","volume":"14","author":"Pipitone","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.exger.2026.113036_bb0140","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.exger.2026.113036_bb0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","article-title":"Telomere dysfunction in ageing and age-related diseases","volume":"24","author":"Rossiello","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"5456","key":"10.1016\/j.exger.2026.113036_bb0150","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.287.5456.1253","article-title":"Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery","volume":"287","author":"Rudolph","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.exger.2026.113036_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.190.2.157","article-title":"Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood","volume":"190","author":"Rufer","year":"1999","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.exger.2026.113036_bb0160","doi-asserted-by":"crossref","first-page":"18004","DOI":"10.1038\/s41598-021-97385-2","article-title":"Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease","volume":"11","author":"Shin","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.exger.2026.113036_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12916-023-03136-7","article-title":"The association between telomere length and non-alcoholic fatty liver disease: a prospective study","volume":"21","author":"Tang","year":"2023","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.exger.2026.113036_bb0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.exger.2026.113036_bb0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00535-024-02181-0","article-title":"Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD","volume":"60","author":"Wang","year":"2025","journal-title":"J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.exger.2026.113036_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142221","article-title":"Role of hepatocyte senescence in the activation of hepatic stellate cells and liver fibrosis progression","volume":"11","author":"Wijayasiri","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.exger.2026.113036_bb0185","doi-asserted-by":"crossref","first-page":"8435178","DOI":"10.1155\/2017\/8435178","article-title":"Shorter leukocyte telomere length in relation to presumed nonalcoholic fatty liver disease in Mexican-American men in NHANES 1999-2002","volume":"2017","author":"Wojcicki","year":"2017","journal-title":"Int J Hepatol."},{"issue":"1","key":"10.1016\/j.exger.2026.113036_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101750","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases","volume":"30","author":"Xiao","year":"2025","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.exger.2026.113036_bb0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/CM9.0000000000002994","article-title":"Association of leukocyte telomere length with the risk of digestive diseases: a large-scale cohort study","volume":"138","author":"Yang","year":"2025","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.exger.2026.113036_bb0200","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.exger.2026.113036_bb0205","series-title":"Shortened Leucocyte Telomere Length Is Associated Independently with Fibrosis Stage in Non-alcoholic Fatty Liver Disease","author":"Zhang","year":"2017"},{"issue":"24","key":"10.1016\/j.exger.2026.113036_bb0210","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1097\/CM9.0000000000000559","article-title":"Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes","volume":"132","author":"Zhang","year":"2019","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/j.exger.2026.113036_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101579","article-title":"Biological aging accelerates hepatic fibrosis: insights from the NHANES 2017-2020 and genome-wide association study analysis","volume":"30","author":"Zhao","year":"2024","journal-title":"Ann. Hepatol."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556526000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556526000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:43:27Z","timestamp":1778633007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556526000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0531556526000148"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2026.113036","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomere length and metabolic dysfunction-associated steatotic liver disease risk and progression: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2026.113036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113036"}}